2型糖尿病视网膜病变患者血浆精氨酸和瓜氨酸升高
这项横断面研究纳入159例糖尿病对照和156例糖尿病视网膜病变(DR)患者(92例非增殖性、64例增殖性),用LC-MS/MS检测六种精氨酸/瓜氨酸相关代谢物。校正肌酐后ADMA在增殖性与非增殖性DR间的差异不再显著。
要点
- DR患者血浆精氨酸和瓜氨酸较糖尿病对照显著升高,校正年龄、性别、HbA1c、病程及用药后仍显著。
- ADMA在增殖性与非增殖性DR间的差异在校正肌酐后不再显著。
- 校正分析中,所测代谢物在增殖性与非增殖性DR间均无显著差异。
核心结论
- 2型糖尿病合并DR患者血浆精氨酸和瓜氨酸水平较糖尿病对照显著升高,但所测代谢物在增殖性与非增殖性DR间校正后无显著差异。
研究设计与样本
- 横断面研究,从Vanderbilt Eye Institute招募2型糖尿病成人,排除非糖尿病性视网膜疾病。
- 纳入159例糖尿病对照和156例DR患者(92例NPDR、64例PDR),用同位素稀释液相色谱-串联质谱(LC-MS/MS)定量血浆代谢物。
- 采用Wilcoxon秩和检验和logistic回归,校正年龄、性别、血红蛋白A1c、糖尿病病程、他汀使用及ACEI或ARB使用。
- 对具有肌酐值的子集(135例糖尿病对照、100例DR患者[58例NPDR、42例PDR])进行二次分析,回归模型额外纳入肌酐。
主要发现
- 校正分析中,所测代谢物在NPDR与PDR患者间均无显著差异。
临床怎么用
- 血浆精氨酸和瓜氨酸升高与2型糖尿病患者的DR相关,提示氨基酸代谢异常可能参与DR。
- ADMA与增殖性DR的关联可能受肾功能影响,解读时需结合肌酐等肾功能指标。
局限性
- 横断面设计无法推断因果关系。
- 二次分析仅纳入具有肌酐值的子集,样本量少于主分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine if plasma levels of six arginine-related and citrulline-related metabolites (arginine, citrulline, asymmetric dimethylarginine [ADMA], ornithine, proline, and argininosuccinate) differ between patients with type 2 diabetes and diabetic retinopathy (DR) and type 2 diabetic controls or between patients with proliferative DR (PDR) and non-proliferative DR (NPDR). DESIGN: Cross-sectional study. METHODS: Adults with type 2 diabetes were recruited from the Vanderbilt Eye Institute. Exclusion criteria included non-diabetic retinal disease. Plasma metabolite levels were quantified in 159 diabetic controls and 156 DR patients (92 NPDR, 64 PDR) using isotope dilution liquid chromatography-tandem mass spectrometry (LC-MS/MS). Metabolite levels were compared using Wilcoxon Rank Sum test and logistic regressions adjusting for age, sex, hemoglobin A1c, diabetes duration, statin use, and angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker use. A secondary analysis that included creatinine in the regression model was performed for the subset of patients with available creatinine values (135 diabetic controls, 100 DR patients [58 NPDR, 42 PDR]). RESULTS: Multivariable logistic regression analyses determined that arginine (OR = 1.20, [1.06-1.38], P = .0067) and citrulline (OR = 1.53, [1.20-1.98], P = .0025) were significantly elevated in DR patients compared to diabetic controls. While ADMA differed between NPDR and PDR patients in the primary analysis (OR = 1.56, [1.15-2.16], P = .0051), it was not significantly different when adjusting for creatinine (OR = 1.30, [0.90-1.91], P = .15). CONCLUSIONS: Plasma arginine and citrulline were significantly elevated in type 2 diabetic patients with DR compared to diabetic controls. None of the tested metabolites significantly differed between NPDR and PDR patients in the adjusted analysis.
引用
- Peters KS, Rivera E, Warden C, et al. Plasma Arginine and Citrulline are Elevated in Diabetic Retinopathy. Am J Ophthalmol. 2021. PMID: 34587493. doi:10.1016/j.ajo.2021.09.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。